Literature DB >> 33776619

A comparison of meal tolerance test and oral glucose tolerance test for predicting insulin therapy in patients with gestational diabetes.

Mai Hijikata1,2, Mariko Higa2, Takamasa Ichijo2, Takahisa Hirose1.   

Abstract

AIMS: To identify factors predicting a need for insulin therapy in gestational diabetes mellitus (GDM) by comparing plasma glucose (PG) levels in a 75-g oral glucose tolerance test (75-g OGTT) with those in a 500-kcal meal tolerance test (MTT) containing 75 g of carbohydrate. SUBJECTS AND METHODS: The MTT was performed in 61 patients who diagnosed with GDM by a 75-g OGTT (age, 33.2 ± 4.5 years; prepregnancy body mass index, 22.6 ± 4.7 kg/m2; number of gestational weeks, 25.1 ± 6.4 weeks). PG and serum insulin levels were measured before the meal and up to 180 min after the meal. The insulin secretion capacity and resistance index were calculated.
RESULTS: PG levels increased from 86.8 ± 8.8 mg/dL at fasting to 132.7 ± 20.1 mg/dL at 30 min, and 137.8 ± 27.7 mg/dL at 60 min after MTT in the 35 patients with needed insulin therapy; these levels were significantly higher than those in the 26 patients, who only needed diet therapy. The patients with needed insulin therapy had significantly higher fasting PG levels in the 75-g OGTT, PG levels at fasting and 30 min after the MTT, and homeostasis model assessment of insulin resistance (HOMA-IR), and a significantly lower disposition index (DI) and insulin index than patients treated by diet alone. Receiver operating characteristic curve analysis was performed for factors involved in insulin therapy, with the following cutoff values: fasting PG in the 75-g OGTT, 92 mg/dL; PG 30 min after MTT, 129 mg/dL; HOMA-IR, 1.51; DI, 3.9; HbA1c, 5.4%. Multivariate analysis revealed that the 30-min PG level after MTT and HOMA-IR predicted insulin therapy.
CONCLUSION: PG levels at 30 min after MTT may be useful for identifying patients with GDM, who need insulin therapy.
© 2021 Mai Hijikata et al.

Entities:  

Keywords:  75-g oral glucose tolerance test; gestational diabetes; insulin resistance; insulin therapy; meal tolerance test

Year:  2021        PMID: 33776619      PMCID: PMC7955519          DOI: 10.29219/fnr.v65.5490

Source DB:  PubMed          Journal:  Food Nutr Res        ISSN: 1654-661X            Impact factor:   3.894


  37 in total

Review 1.  Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes.

Authors:  T A Buchanan
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

2.  Fasting plasma glucose and body mass index during the first trimester of pregnancy as predictors of gestational diabetes mellitus in a Chinese population.

Authors:  Min Hao; Li Lin
Journal:  Endocr J       Date:  2017-04-14       Impact factor: 2.349

3.  Clinical impact of women with gestational diabetes mellitus by the new consensus criteria: two year experience in a single institution in Japan.

Authors:  Satoru Ikenoue; Kei Miyakoshi; Yoshifumi Saisho; Kensuke Sakai; Yoshifumi Kasuga; Marie Fukutake; Yoko Izumi; Tadashi Matsumoto; Kazuhiro Minegishi; Yasunori Yoshimura
Journal:  Endocr J       Date:  2014-01-16       Impact factor: 2.349

4.  Single glucose challenge test procedure for diagnosis of gestational diabetes mellitus: a Jammu cohort study.

Authors:  Kavita Sharma; Preeti Wahi; Anupriya Gupta; Ketki Jandial; Rajesh Bhagat; Rajesh Gupta; Sunil Gupta; Jitendra Singh
Journal:  J Assoc Physicians India       Date:  2013-08

5.  Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women.

Authors:  P M Catalano; E D Tyzbir; N M Roman; S B Amini; E A Sims
Journal:  Am J Obstet Gynecol       Date:  1991-12       Impact factor: 8.661

6.  Hyperglycemia and adverse pregnancy outcomes.

Authors:  Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

7.  Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.

Authors:  Ravi Retnakaran; Sandy Shen; Anthony J Hanley; Vladimir Vuksan; Jill K Hamilton; Bernard Zinman
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

Review 8.  14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

9.  One-hour oral glucose tolerance test plasma glucose at gestational diabetes diagnosis is a common predictor of the need for insulin therapy in pregnancy and postpartum impaired glucose tolerance.

Authors:  Takeshi Nishikawa; Keiko Ono; Shoko Hashimoto; Hiroyuki Kinoshita; Takuro Watanabe; Hirotaka Araki; Kae Otsu; Wakana Sakamoto; Masahiro Harada; Tetsushi Toyonaga; Shoichi Kawakami; Jyunichiro Fukuda; Yoshio Haga; Daisuke Kukidome; Takeshi Takahashi; Eiich Araki
Journal:  J Diabetes Investig       Date:  2018-04-29       Impact factor: 4.232

10.  Metabolic Culprits in Obese Pregnancies and Gestational Diabetes Mellitus: Big Babies, Big Twists, Big Picture : The 2018 Norbert Freinkel Award Lecture.

Authors:  Linda A Barbour
Journal:  Diabetes Care       Date:  2019-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.